Tumor growth kinetics showed that siRNA-mediated knockdown of CERK inhibited the BT-474 tumor growth as compared to other groups (Figure 7A), and there was a >2.5-fold (p < 0.0001) decrease in tumor volume on final day (Figure 7B,C). Here, CERK is linked to neoplasm.